| scholarly article | Q13442814 |
| P2093 | author name string | Dillip K Mohanty | |
| Philip J Squattrito | |||
| John A Wisniewski | |||
| Alec R Badour | |||
| P2860 | cites work | A short history of SHELX | Q25938995 |
| Water-soluble poly(ethylenimine)-based nitric oxide donors: preparation, characterization, and potential application in hemodialysis | Q31059963 | ||
| Sustained nitric oxide (NO)-releasing compound reverses dysregulated NO signal transduction in priapism | Q33713601 | ||
| Nitric oxide and the proliferation of vascular smooth muscle cells | Q33847601 | ||
| Slow and sustained nitric oxide releasing compounds inhibit multipotent vascular stem cell proliferation and differentiation without causing cell death | Q33935039 | ||
| Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease | Q35010064 | ||
| Effects of slow, sustained, and rate-tunable nitric oxide donors on human aortic smooth muscle cells proliferation | Q35209508 | ||
| Crystal structure refinement with SHELXL. | Q35539543 | ||
| Recent developments in nitric oxide donor drugs. | Q36052815 | ||
| Alcohol and the cardiovascular system: research challenges and opportunities | Q36166568 | ||
| Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates | Q36416588 | ||
| Secondary amines containing one aromatic nitro group: preparation, nitrosation, sustained nitric oxide release, and the synergistic effects of released nitric oxide and an arginase inhibitor on vascular smooth muscle cell proliferation | Q36614973 | ||
| Aspects of nitric oxide in health and disease: a focus on hypertension and cardiovascular disease | Q36684781 | ||
| Nitric oxide in shock | Q36835542 | ||
| A series of N-(2-phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents | Q37281375 | ||
| Strategies to increase nitric oxide signalling in cardiovascular disease | Q38565004 | ||
| Determination of absolute structure using Bayesian statistics on Bijvoet differences. | Q40373988 | ||
| Use of intensity quotients and differences in absolute structure refinement | Q40934629 | ||
| Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols. | Q42466708 | ||
| N,N'-diethyl-4-nitrobenzene-1,3-diamine, 2,6-bis(ethylamino)-3-nitrobenzonitrile and bis(4-ethylamino-3-nitrophenyl) sulfone | Q42984225 | ||
| Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase | Q44480706 | ||
| Extracellular nitric oxide release mediates soluble guanylate cyclase-independent vasodilator action of spermine NONOate: comparison with other nitric oxide donors in isolated rat femoral arteries | Q44838860 | ||
| P433 | issue | Pt 5 | |
| P304 | page(s) | 405-410 | |
| P577 | publication date | 2016-04-13 | |
| P1433 | published in | Acta crystallographica. Section C, Structural chemistry | Q27725273 |
| P1476 | title | Two N-(2-phenylethyl)nitroaniline derivatives as precursors for slow and sustained nitric oxide release agents | |
| P478 | volume | 72 |
Search more.